SwePub
Sök i LIBRIS databas

  Utökad sökning

(WFRF:(Sherman Mark)) mspu:(article)
 

Sökning: (WFRF:(Sherman Mark)) mspu:(article) > Alcohol Consumption...

LIBRIS Formathandbok  (Information om MARC21)
FältnamnIndikatorerMetadata
00006074naa a2200961 4500
001oai:lup.lub.lu.se:4179cc51-5ed8-40f8-81d8-9b7f3602c0b9
003SwePub
008160401s2014 | |||||||||||000 ||eng|
009oai:prod.swepub.kib.ki.se:130135265
009oai:DiVA.org:umu-97608
0247 a https://lup.lub.lu.se/record/49856822 URI
0247 a https://doi.org/10.1158/1055-9965.EPI-13-09012 DOI
0247 a http://kipublications.ki.se/Default.aspx?queryparsed=id:1301352652 URI
0247 a https://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-976082 URI
040 a (SwePub)lud (SwePub)kid (SwePub)umu
041 a engb eng
042 9 SwePub
072 7a art2 swepub-publicationtype
072 7a ref2 swepub-contenttype
1001 a Ali, Alaa M. G.4 aut
2451 0a Alcohol Consumption and Survival after a Breast Cancer Diagnosis: A Literature-Based Meta-analysis and Collaborative Analysis of Data for 29,239 Cases
264 1c 2014
520 a Background: Evidence for an association of alcohol consumption with prognosis after a diagnosis of breast cancer has been inconsistent. We have reviewed and summarized the published evidence and evaluated the association using individual patient data from multiple case cohorts. Methods: A MEDLINE search to identify studies published up to January 2013 was performed. We combined published estimates of survival time for "moderate drinkers" versus nondrinkers. An analysis of individual participant data using Cox regression was carried out using data from 11 case cohorts. Results: We identified 11 published studies suitable for inclusion in the meta-analysis. Moderate postdiagnosis alcohol consumption was not associated with overall survival [HR, 0.95; 95% confidence interval (CI), 0.85-1.05], but there was some evidence of better survival associated with prediagnosis consumption (HR, 0.80; 95% CI, 0.73-0.88). Individual data on alcohol consumption for 29,239 cases with 4,839 deaths were available from the 11 case cohorts, all of which had data on estrogen receptor (ER) status. For women with ER-positive disease, there was little evidence that pre-or postdiagnosis alcohol consumption is associated with breast cancer-specific mortality, with some evidence of a negative association with all-cause mortality. On the basis of a single study, moderate postdiagnosis alcohol intake was associated with a small reduction in breast cancer-specific mortality for women with ER-negative disease. There was no association with prediagnosis intake for women with ER-negative disease. Conclusion: There was little evidence that pre- or post-diagnosis alcohol consumption is associated with breast cancer-specific mortality for women with ER-positive disease. There was weak evidence that moderate post-diagnosis alcohol intake is associated with a small reduction in breast cancer-specific mortality in ER-negative disease. Impact: Considering the totality of the evidence, moderate postdiagnosis alcohol consumption is unlikely to have a major adverse effect on the survival of women with breast cancer. (C) 2014 AACR.
650 7a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Cancer och onkologi0 (SwePub)302032 hsv//swe
650 7a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Cancer and Oncology0 (SwePub)302032 hsv//eng
7001 a Schmidt, Marjanka K.4 aut
7001 a Bolla, Manjeet K.4 aut
7001 a Wang, Qin4 aut
7001 a Gago-Dominguez, M.4 aut
7001 a Esteban Castelao, J.4 aut
7001 a Carracedo, Angel4 aut
7001 a Munoz Garzon, Victor4 aut
7001 a Bojesen, Stig E.4 aut
7001 a Nordestgaard, Borge G.4 aut
7001 a Flyger, Henrik4 aut
7001 a Chang-Claude, Jenny4 aut
7001 a Vrieling, Alina4 aut
7001 a Rudolph, Anja4 aut
7001 a Seibold, Petra4 aut
7001 a Nevanlinna, Heli4 aut
7001 a Andersson, Anneu Umeå universitet,Onkologi4 aut0 (Swepub:umu)ankr0012
7001 a Aaltonen, Kirsimari4 aut
7001 a Blomqvist, Carl4 aut
7001 a Matsuo, Keitaro4 aut
7001 a Ito, Hidemi4 aut
7001 a Iwata, Hiroji4 aut
7001 a Horio, Akiyo4 aut
7001 a John, Esther M.4 aut
7001 a Sherman, Mark4 aut
7001 a Lissowska, Jolanta4 aut
7001 a Figueroa, Jonine4 aut
7001 a Garcia-Closas, Montserrat4 aut
7001 a Anton-Culver, Hoda4 aut
7001 a Shah, Mitul4 aut
7001 a Hopper, John L.4 aut
7001 a Trichopoulou, Antonia4 aut
7001 a Bueno-de-Mesquita, Bas4 aut
7001 a Krogh, Vittorio4 aut
7001 a Weiderpass, Elisabeteu Karolinska Institutet4 aut
7001 a Andersson, Anne4 aut
7001 a Clavel-Chapelon, Francoise4 aut
7001 a Dossus, Laure4 aut
7001 a Fagherazzi, Guy4 aut
7001 a Peeters, Petra H.4 aut
7001 a Olsen, Anja4 aut
7001 a Wishart, Gordon C.4 aut
7001 a Easton, Douglas F.4 aut
7001 a Borgquist, Signeu Lund University,Lunds universitet,Bröstcancer-genetik,Sektion I,Institutionen för kliniska vetenskaper, Lund,Medicinska fakulteten,Breastcancer-genetics,Section I,Department of Clinical Sciences, Lund,Faculty of Medicine4 aut0 (Swepub:lu)ront-sbo
7001 a Overvad, Kim4 aut
7001 a Barricarte, Aurelio4 aut
7001 a Gonzalez, Carlos A.4 aut
7001 a Sanchez, Maria-Jose4 aut
7001 a Amiano, Pilar4 aut
7001 a Riboli, Elio4 aut
7001 a Key, Tim4 aut
7001 a Pharoah, Paul D.4 aut
7102 a Umeå universitetb Onkologi4 org
7730 t Cancer Epidemiology Biomarkers & Preventiong 23:6, s. 934-945q 23:6<934-945x 1538-7755x 1055-9965
8564 u http://dx.doi.org/10.1158/1055-9965.EPI-13-0901y FULLTEXT
8564 8u https://lup.lub.lu.se/record/4985682
8564 8u https://doi.org/10.1158/1055-9965.EPI-13-0901
8564 8u http://kipublications.ki.se/Default.aspx?queryparsed=id:130135265
8564 8u https://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-97608

Hitta via bibliotek

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy